(Press-News.org) UC Davis researchers have found a new pathway for repairing DNA damaged by oxygen radicals. The results are published this week in the journal Proceedings of the National Academy of Sciences.
"This new inducible pathway gives cells greater capacity to repair oxidative damage," said Peter Beal, professor of chemistry at UC Davis and senior author of the paper.
As part of its inflammatory response, the body's immune system produces oxygen radicals, or reactive oxygen species, to kill bacteria, parasites or tumors. But chronic inflammation, for example in the gut, has been linked to cancer, said co-author Professor Sheila David, also of the Department of Chemistry.
Oxygen radicals are strongly linked to cancer and aging and are also formed during metabolism and upon exposure to environmental toxins and radiation. Understanding more about how this damage can be repaired could lead to a better understanding of the causes of some cancers.
Oxygen radicals can react with the four bases that make up the "letters" of DNA -- A, C, G and T -- so that the "spelling" of genes gets changed. The accumulation of spelling errors (called mutations) can lead to cancer.
David's laboratory studies an enzyme called NEIL1 that detects and repairs these aberrant or damaged bases before changes in the genome become permanent.
Beal's group works on RNA editing. The first step in turning a gene into a protein is to make a copy of the DNA in RNA. This messenger RNA is then translated into the chain of amino acids that makes up a protein. In some cases, this RNA is "edited" between the transcription from DNA and the translation into protein.
At a conference last year, Beal -- who happens to be David's husband -- spotted NEIL1 among a list of genes that had just been discovered to be subject to RNA editing, and passed the news on to David.
On investigation, they found that NEIL1's messenger RNA is edited by an enzyme called ADAR1. In that editing, one of the chains of amino acids that make up NEIL1 changes from lysine to arginine, causing a slight, but noticeable, change in the structure of the protein.
Using a cell line derived from nerve cells, the team found no editing of NEIL1 RNA in resting cells. But when the cells were treated with interferon, which is produced during inflammation and to fight off viruses, the cells started making ADAR1 and editing NEIL1.
"The interferon-treated cells had two forms of the NEIL1 protein, one with lysine and one with arginine," Beal said.
NEIL1 can fix a number of different damaged DNA bases that form when normal DNA bases are attacked by oxygen radicals. Beal and David found that the two different forms of NEIL1 had different abilities to act upon the damaged DNA bases: the basic, lysine version had a broader range but lower activity, while the edited, arginine form had higher activity but was effective against a more limited range of targets. That might give the cell more flexibility in responding to DNA damage.
Beal and David believe that the whole system works something like this: Inflammation creates oxygen radicals, which damage DNA, which is repaired by NEIL1. Inflammation also generates interferon, which induces ADAR1, which then edits NEIL1 to produce the more active, specific form to cope with more severe types of DNA base damage.
INFORMATION:
The other co-authors on the paper are Jongchan Yeo, Rena Goodman and Nicole Schirle, all graduate students in the Department of Chemistry. The work was supported by grants from the National Institute for General Medical Sciences and the National Cancer Institute, both parts of the National Institutes of Health.
New DNA repair pathway
2010-11-10
ELSE PRESS RELEASES FROM THIS DATE:
Cancer experience worse for young adults in spite of better survival odds
2010-11-10
ANN ARBOR, Mich. – Younger adult cancer patients have the most difficulty coping with the pain and emotional issues of cancer, in spite of their potentially better survival odds, according to a University of Michigan Health System study.
The study, which included mostly breast and lung cancer patients, appears in the November issue of Pain Medicine, a journal of the American Academy of Pain Medicine.
Adult cancer patients age 40 and under had more pain flares and more difficulty thinking quickly and logically six months after their diagnosis compared to older adults. ...
Zebrafish reveal exquisite workings of the brain
2010-11-10
VIDEO:
A UCSF-led team has discovered a neural mechanism that allows the translucent juvenile zebrafish to parse out large background patterns from its perception of visual surroundings, enabling it to see...
Click here for more information.
A tiny, translucent juvenile zebrafish, on the hunt for even littler prey, has offered up a big insight into how a specific circuit of nerve cells functions in the brain. The technique used to illuminate this circuitry, and the fish model ...
Use of androgen deprivation therapy increases fracture risk among prostate cancer patients
2010-11-10
PHILADELPHIA — Men with history of fracture and comorbidities are at an increased risk of fracture after long-term use of androgen deprivation therapy, and initiating this therapy should be carefully considered in older men with localized prostate cancer.
In addition, the longer duration of gonadotropin-releasing hormone (Gn-RH) use and history of orchiectomy (removal of the testicles to stop testosterone production, which prostate cancer needs to continue to grow) are also associated with an increased risk of fracture among men with prostate cancer.
These study results ...
Home exposure to tobacco carcinogens high in children of smokers
2010-11-10
PHILADELPHIA — Ninety percent of children who lived in a house where an adult smoked had evidence of tobacco-related carcinogens in their urine, according to research presented at the Ninth AACR Frontiers in Cancer Prevention Research Conference, held here from Nov 7-10, 2010.
The average amount of tobacco metabolites in children aged one month to 10 years old was 8 percent of what is found in a smoker, said the lead researcher Janet L. Thomas, Ph.D., assistant professor of behavioral medicine at the University of Minnesota.
"This finding is striking, because while ...
Menopausal hormone therapy may increase risk of ovarian cancer
2010-11-10
PHILADELPHIA — Women planning on taking hormone therapy for the treatment of menopausal symptoms should be aware of a possible increased risk for ovarian cancer, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
"This study is consistent with previous recommendations that say if women are going to take hormones they should only take them in the short term," said Konstantinos Tsilidis, Ph.D., a postdoctoral fellow at the Cancer Epidemiology Unit at the University of Oxford.
Tsilidis and ...
Side effects of hormonal breast cancer therapy increased; may affect treatment adherence
2010-11-10
PHILADELPHIA — Women being treated for breast cancer with aromatase inhibitors may experience extremely low estrogen levels resulting in a wide variety of side effects that a typical postmenopausal woman without cancer may not experience.
Data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Conference, held here Nov. 7-10, 2010, showed that women assigned to take aromatase inhibitors had increases in side effects such as hot flashes, decreased appetite, fatigue, fever, breast sensitivity, etc.
"Aromastase inhibitors represent one of the most major ...
Exercise may reduce risk of endometrial cancer
2010-11-10
PHILADELPHIA — Women who exercise for 150 minutes a week or more may see a reduced risk of endometrial cancer, despite whether or not they are overweight, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
"This study is consistent with other studies that strongly support the association between physical activity and lower risk of endometrial cancer," said Hannah Arem, a doctoral student at Yale School of Public Health.
Arem and colleagues examined data collected from a case-control study ...
Long-term statin use is unlikely to increase cancer risk
2010-11-10
PHILADELPHIA — Researchers have further established that long-term use of statins is unlikely to substantially increase or decrease overall cancer risk, according to study results presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10, 2010, in Philadelphia.
Statins are a class of drugs commonly used in the United States to lower cholesterol and reduce the risk of cardiovascular disease. While study results to date have shown that short-term use of statins has little effect on risk of developing cancer, not much is known ...
Very few eligible young women opt to take HPV vaccine
2010-11-10
PHILADELPHIA — Despite strong evidence of its effectiveness, few of the young women who are eligible for the human papillomavirus (HPV) vaccine take it, according to research presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10. What's more, many of the teens who begin treatment do not complete the recommended three-dose regimen.
"Only about one-third of young women who begin the three-dose series actually complete it; this means that large numbers of teenagers are unprotected or under-protected from strains of HPV that ...
Obesity in adolescence significantly associated with increased risk of severe obesity in adulthood
2010-11-10
An analysis of nationally representative data suggests that being obese in adolescence increases the risk of being severely obese in adulthood, with the risk higher in women, and highest for black women, according to a study in the November 10 issue of JAMA.
Individuals with severe obesity (body mass index [BMI] 40 or greater) encounter serious and potentially life-threatening health complications. "In 2000, an estimated 2.2 percent of adults, or 4.8 million individuals, were severely obese, with a disproportionately higher prevalence in women and racial/ethnic minorities. ...